Login

ReNeuron focus on new clinical trials - Michael Hunt, Chief Financial Officer, ReNeuron Group 00:00:00

Share On Facebook Share On Twitter

ReNeuron Group (RENE) is a biotechnology firm. The principal of the business involves the research and development of stem cell technology for the treatment of motor disabilities and blindness-causing diseases.

Recent Videos

00:10:00
Thomas Olin Highlights Kancera’s Latest Advances and Strategic Focus | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Pablo Pereiro Discusses Squirrel Media’s 63% Profit Growth and 14.7% Stock Surge | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Steve Oliver of musicMagpie Discusses Circular Economy and Company's Growth Strategy | Steve Oliver , CEO , musicMagpie PLC.
00:10:00
Revolutionizing Healing with Naturally Derived Psychedelics | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
SMC Global Securities Launches New Office at Bahu Plaza, Jammu, to Promote Share Market Investments | Ajay Garg , CEO , SMC Global Securities Ltd.
00:10:00
Exploring Demoralization Syndrome Treatment with Filament Health’s Psilocybin Trials | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
BioInvent CEO Explores Portfolio Strategy and Upcoming Breakthroughs | Dr. Martin Welschof, CEO , BioInvent International AB.
00:10:00
Piotr Figarski Discusses Image Power's 2022 Results and Future Trends | Piotr Figarski, Vice President , Image Power SA.
00:10:00
Pablo Pereiro and María Bonaria Fois Discuss Squirrel Media's Strategic Acquisition of Mondo TV Studios | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Lexington Gold Set to List on London AIM Exchange After Reverse Takeover | Dr. Bernard Olivier, CEO , Lexington Gold Ltd.
00:10:00
Thomas Olin, CEO of Kancera AB, Discusses Strategic Advances in Biopharma Innovation | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Leading the Charge in the Psychedelic Movement with Filament Health | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
Pini Mandel on the Power of Dynamic Pricing to Boost Retail KPIs and Customer Satisfaction | Pini Mandel , CEO , Quicklizard Ltd.
00:10:00
Jean Michel Ng Tseung, New CEO of MCB Group, Shares Vision for a Sustainable Future | Jean Michel Ng Tseung , CEO , MCB Group Ltd.
00:10:00
Viktor Garmiani Unveils Candles Scandinavia’s Q4 Report Highlights | Viktor Garmiani, CEO , Candles Scandinavia AB.
00:10:00
Squirrel Media's Record-Breaking Year: CEO Pablo Pereiro Discusses Key Strategies and Global Expansion | Pablo Pereiro , CEO , Squirrel Media SA.

Suggestions

00:10:00
Michael F Schein: What Punk Rock Teaches Us About Marketing | Mathieu Bonnet, CEO, Allego NVALLG:NYQ
00:10:00
"Navigating Market Volatility: Javid Mirza's Insights on Economic Challenges and Portfolio Strategies at Canaccord Genuity"
00:10:00
Stephen Schwarzman on the Fitch Downgrade and U.S. Political Landscape | Stephen A. Schwarzman, CEO , The Blackstone Group Inc.
00:00:00
Well-recognized leader in Pathology and Immunology education/Andrew Lichtman, MD, PhD Professor of Pathology at Harvard Medical School
00:10:00
Accelerating Energy Transition: Javier Div's Commitment to Collaboration and Sustainability | Javier Dib , CEO, AES Andes SA.
00:10:00
Oak Tree's Integrity: Fostering Responsibility, Leadership, and Growth Since 2002 | Robert O’Leary , CO-CEO ,  Oaktree Capital Management.
00:10:00
Interview with John Floric: AI in Gold Mining and Market Insights
00:10:00
Q2 2024 Market Trends and Q3 Outlook: A Comprehensive Review | David W. Shotwell, CEO, Shotwell Rutter Baer.
00:00:00
Lab studies eukaryotic gene expression / Stephen Buratowski, Ph.D. Hamilton Kuhn Professor of Biological Chemistry and Molecular Pharmacology, HMS
00:10:00
Founders Metals: Progress, Discoveries, and Future Prospects in Guyana's Gold Exploration
00:10:00
Rob McEwen on Building Goldcorp and McEwen Mining: From InA12:G14vestments to Mining Leadership
00:10:00
Discussion on Sparkle Study Enrollment, Endpoints, FDA Designation, and Market Potential for Novel Drug|Magnus Corfitzen, CEO, Ascelia Pharma AB.

© 2017 - Townhall + Tv